APYX
Apyx Medical Inc
3.00$
+4.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +26.6% | +11.6% | -11.7% | +208.5% | -11.4% | -12.5% | -7.3% | -24.7% | +53.0% | -18.2% | +3.1% | |
| – | +43.5% | +20.4% | -15.0% | +297.0% | -14.4% | -13.8% | -8.1% | -29.2% | +63.7% | -19.8% | +3.6% | |
| – | +105.9% | +22.5% | -31.2% | +65.5% | +257.2% | -28.7% | -26.4% | -67.0% | +328.3% | -27.3% | 0.0% | |
| – | +105.9% | +22.5% | -31.2% | +685.4% | -24.7% | -28.7% | -26.4% | -67.0% | +328.3% | -27.3% | 0.0% | |
| – | +46.8% | +61.8% | +2.6% | +4.6% | +81.5% | +87.9% | +22.1% | -13.8% | -23.1% | +10.4% | +8.4% | |
| – | +4.0% | +3.4% | +6.0% | -20.1% | -3.1% | -19.8% | +67.3% | +74.0% | -15.9% | -23.8% | +13.7% | |
| – | -2.0% | -5.3% | -0.6% | -9.7% | +14.3% | +9.0% | -8.9% | +2.8% | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | |
| – | -5.6% | -5.9% | -2.1% | -99.6% | – | – | – | – | – | – | – | |
| – | -60.1% | +10.5% | +0.8% | -12.4% | +71.1% | -23.6% | +43.5% | -5.0% | +274.2% | -3.5% | +3.0% | |
| – | +9.4% | +27.9% | +13.3% | +28.9% | +58.9% | -25.2% | +44.3% | -10.3% | +7.5% | -15.8% | +9.1% | |
| – | +0.0% | +0.0% | +0.0% | – | – | -23.7% | -21.2% | -11.8% | +45.1% | -3.3% | +20.6% | |
| – | -21.8% | +32.3% | -1.4% | -10.1% | +71.3% | -38.0% | +74.1% | +1.4% | +1.6% | -3.6% | +16.9% | |
| – | -78.8% | -15.2% | -8.4% | -94.6% | – | – | – | – | – | +2.1% | +2.8% | |
| – | +398.6% | +12.0% | -16.0% | +298.4% | -18.8% | -10.6% | -15.7% | -30.0% | -29.0% | -46.8% | +2.3% | |
| – | – | – | – | – | -59.1% | -81.9% | -578.9% | – | – | – | – | |
| – | +56.3% | -1.1% | +14.5% | +9.4% | -0.9% | +0.4% | +0.4% | +0.5% | +0.3% | +2.7% | +18.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.